Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Age and Ageing|February 10, 2017
Tolerance of subcutaneously administered antibiotics: a French national prospective studyClaire Roubaud-Baudron, Emmanuel Forestier, Thibaut Fraisse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)?Jacques Gaillat, Vincent Gajdos, Odile Launay, et al.
Journal of Epidemiology and Population Health|March 20, 2025
Étude de cohorte rétrospective à l'échelle nationale visant à évaluer l'efficacité vaccinale relative du vaccin grippal haute dose par rapport aux vaccins dose standard chez les adultes de plus de 65 ans vivant en communauté en France au cours de la saison 2022-2023Hélène Bricout, Fanny Raguideau, Marie-Cécile Levant, et al.
BMJ Open|November 12, 2020
Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and populationAnne-Laure Mounayar, Patrice Francois, Patricia Pavese, et al.
BMJ Open Respiratory Research|November 7, 2024
Agreement and comparative accuracy of instability criteria at discharge for predicting adverse events in patients with community-acquired pneumoniaAnne Danjou, Magali Bouisse, Bastien Boussat, et al.
Age and Ageing|March 5, 2014
Aminoglycosides use in patients over 75 years oldThibaut Fraisse, Claudine Gras Aygon, Marc Paccalin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 27, 2017
Costs associated with community acquired pneumonia in FranceGrèce Saba, Luiz Flavio Andrade, Jacques Gaillat, et al.
Health and Quality of Life Outcomes|February 4, 2018
Health related quality of life in patients with community-acquired pneumococcal pneumonia in FranceLuiz Flavio Andrade, Grèce Saba, Jean-Damien Ricard, et al.
Therapeutic Advances in Vaccines|October 20, 2015
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveRobert W Johnson, Marie-José Alvarez-Pasquin, Marc Bijl, et al.
JAMA Network Open|April 8, 2022
Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in FranceBastien Boussat, Fabiana Cazzorla, Marion Le Marechal, et al.
Pageof 4